help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flodstrom, M.
Right arrow Articles by Eizirik, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flodstrom, M.
Right arrow Articles by Eizirik, D. L.

Endocrinology, Vol 136, 3200-3206, Copyright © 1995 by Endocrine Society


ARTICLES

Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic beta-cells: induction of argininosuccinate synthetase by cytokines

M Flodstrom, A Niemann, FJ Bedoya, SM Morris Jr and DL Eizirik
Department of Medical Cell Biology, Uppsala University, Sweden.

Nitric oxide (NO) may be a mediator of beta-cell damage in insulin- dependent diabetes mellitus. beta-Cells express the inducible form of NO synthase (iNOS) and produce large amounts of NO upon exposure to cytokines. iNOS requires the amino acid arginine for NO formation. It has been shown in other cell types that interferon-gamma (IFN gamma) and bacterial lipopolysaccharide induce the enzyme argininosuccinate synthetase (AS), enhancing the capacity of these cells to regenerate arginine from citrulline and maintain NO production in the presence of low arginine concentrations. To characterize the messenger RNA (mRNA) expression of AS in insulin-producing cells, RINm5F cells (RIN cells) were exposed to interleukin-1 beta (IL-1 beta) or to tumor necrosis factor-alpha plus IFN gamma. After 4-6 h, there was a significant and parallel induction of AS and iNOS mRNA. IL-1 beta-induced AS and iNOS mRNA expression was prevented by an inhibitor of the activation factor NF-kappa B pyrrolidine diaminoguanidine, an inhibitor of gene transcription (actinomycin D), and a blocker of protein synthesis (cycloheximide), suggesting coregulation of AS and iNOS by cytokines. RIN cells exposed to IL-1 beta in the presence of citrulline but the absence of arginine had increased AS enzyme activity and produced NO, demonstrating that cytokine-induced AS mRNA expression is accompanied by increased AS activity. Both adult rat islets exposed to IL-1 beta and human pancreatic islets cultured in the presence of IL-1 beta, tumor necrosis factor-alpha, and IFN gamma were able to use citrulline to regenerate arginine and produce NO. Taken as a whole, the present data suggest that regulation of AS activity may play a role in modulation of NO production in both rodent and human insulin-producing cells.


This article has been cited by other articles:


Home page
J. Nutr.Home page
M. Mori
Regulation of Nitric Oxide Synthesis and Apoptosis by Arginase and Arginine Recycling
J. Nutr., June 1, 2007; 137(6): 1616S - 1620S.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Z. Ma, N. Portwood, D. Brodin, V. Grill, and A. Bjorklund
Effects of Diazoxide on Gene Expression in Rat Pancreatic Islets Are Largely Linked to Elevated Glucose and Potentially Serve to Enhance {beta}-Cell Sensitivity
Diabetes, April 1, 2007; 56(4): 1095 - 1106.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Mori and T. Gotoh
Arginine Metabolic Enzymes, Nitric Oxide and Infection
J. Nutr., October 1, 2004; 134(10): 2820S - 2825S.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. I. Darville, S. Terryn, and D. L. Eizirik
An Octamer Motif Is Required for Activation of the Inducible Nitric Oxide Synthase Promoter in Pancreatic {beta}-Cells
Endocrinology, March 1, 2004; 145(3): 1130 - 1136.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Kutlu, A. K. Cardozo, M. I. Darville, M. Kruhoffer, N. Magnusson, T. Orntoft, and D. L. Eizirik
Discovery of Gene Networks Regulating Cytokine-Induced Dysfunction and Apoptosis in Insulin-Producing INS-1 Cells
Diabetes, November 1, 2003; 52(11): 2701 - 2719.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Cnop, J. C. Hannaert, A. Y. Grupping, and D. G. Pipeleers
Low Density Lipoprotein Can Cause Death of Islet {beta}-Cells by Its Cellular Uptake and Oxidative Modification
Endocrinology, September 1, 2002; 143(9): 3449 - 3453.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. K. Cardozo, M. Kruhøffer, R. Leeman, T. Ørntoft, and D. L. Eizirik
Identification of Novel Cytokine-Induced Genes in Pancreatic {beta}-Cells by High-Density Oligonucleotide Arrays
Diabetes, May 1, 2001; 50(5): 909 - 920.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M.-C. Chen, V. Paez-Espinosa, N. Welsh, and D. L. Eizirik
Interleukin-1{beta} Regulates Phospholipase D-1 Expression in Rat Pancreatic {beta}-Cells
Endocrinology, August 1, 2000; 141(8): 2822 - 2828.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Xie and S. S. Gross
Argininosuccinate Synthetase Overexpression in Vascular Smooth Muscle Cells Potentiates Immunostimulant-induced NO Production
J. Biol. Chem., June 27, 1997; 272(26): 16624 - 16630.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society